medscopeglobal.com · Léky · EMA
Léková novinka
Schváleno13. července 2026
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised
medscopeglobal.com · Léky · EMA
Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised